MedTrace Logo

Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm

NCT01511328 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270000

Last updated 2024-05-16

No results posted yet for this study

Summary

The purpose is to evaluate whether implementation of primary human papillomavirus (HPV) screening in the screening programme for cervical cancer improves the programme in terms of better cancer protection and better cost efficiency.

Conditions

  • High-grade Cervical Intraepithelial Neoplasia
  • Invasive Cervical Cancer

Interventions

OTHER

HPV testing

Testing for Human Papilloma Virus

Sponsors & Collaborators

Principal Investigators

  • Joakim Dillner, MD, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2017-06-30
Completion
2031-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511328 on ClinicalTrials.gov